Overview

Surveillance of Patients With Suspected Acute Myocardial Infarction That Receive Early Inhospital Thrombolysis With Metalyse

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

Obtaining data on efficacy (e.g. complete ST-segment resolution) depending on the time of treatment initiation and safety of prehospital and early hospital thrombolysis with Metalyse® in a real life setting outside clinical trials.

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Tenecteplase
Tissue Plasminogen Activator